Rapport Therapeutics (RAPP) Shares Issued (2024 - 2026)

Rapport Therapeutics (RAPP) has 3 years of Shares Issued data on record, last reported at $809000.0 in Q1 2026.

  • On a quarterly basis, Shares Issued rose 13383.33% to $809000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $2.2 million, a 254.97% increase, with the full-year FY2025 number at $1.3 million, down 99.15% from a year prior.
  • Shares Issued reached $809000.0 in Q1 2026 per RAPP's latest filing, up from $706000.0 in the prior quarter.
  • Over the last five years, Shares Issued for RAPP hit a ceiling of $809000.0 in Q1 2026 and a floor of -$1.4 million in Q3 2024.
  • A 3-year average of $152600.0 and a median of $636000.0 in 2025 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: skyrocketed 145.62% in 2025, then surged 13383.33% in 2026.
  • Tracing RAPP's Shares Issued over 3 years: stood at -$1.4 million in 2024, then skyrocketed by 150.65% to $706000.0 in 2025, then grew by 14.59% to $809000.0 in 2026.
  • Business Quant data shows Shares Issued for RAPP at $809000.0 in Q1 2026, $706000.0 in Q4 2025, and $636000.0 in Q3 2025.